Method for Administering a Medicament to a Fetus
US-2015057505-A1 · Feb 26, 2015 · US
US11660435B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11660435-B2 |
| Application number | US-202017642345-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2020 |
| Priority date | Oct 7, 2019 |
| Publication date | May 30, 2023 |
| Grant date | May 30, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The devices, assemblies, and methods described herein utilize photoacoustic principals to create a jet of fluid using a ultrasonic resonance member and a pulsed laser light beam. The ultrasonic resonance member is a treated substrate having an liquid interface surface in contact with a fluid. When a pulsed laser light beam is applied to the treated substrate, pressure is generated via induced ultrasonic waves to urge the fluid into a jet stream.
Opening claim text (preview).
What is claimed is: 1. An ingestible fluid delivery device comprising: a body including one or more walls defining an interior and having one or more outlets extending through the one or more walls; an ultrasonic resonance member comprising a treated substrate having a fluid interface surface; a laser light source oriented to direct a pulsed light beam at the ultrasonic resonance member to urge a fluid therapeutic disposed within the interior into a jet stream; a controller configured to control operation of the laser light source; and an isolator extending across the interior of the body to divide the interior into a laser compartment and a fluid compartment, wherein the one or more outlets extend through the one or more walls into the fluid compartment and the laser light source is disposed within the laser compartment. 2. The ingestible fluid delivery device of claim 1 , wherein the ultrasonic resonance member comprises either (a) a plate, the fluid interface surface comprises at least one of a plurality of main surfaces of the plate, and the one or more outlets are aligned with the fluid interface surface across a portion of the interior, or (b) a rod, the fluid interface surface comprises an annular outer surface of the rod, and the one or more outlets are aligned radially outward of the rod across a portion of the interior. 3. The ingestible fluid delivery device of claim 1 , wherein the laser light source is configured to direct a pulsed light beam at the ultrasonic resonance member through the isolator. 4. The ingestible fluid delivery device of claim 1 , wherein the laser light source is configured to direct a pulsed light beam at the isolator to urge the fluid therapeutic into a jet stream. 5. The ingestible fluid delivery device of claim 1 , further comprising a pH sensor; and wherein the controller is configured to activate the laser light source in response to the pH sensor determining that the body is in an environment having a pH value above a predetermined threshold. 6. The ingestible fluid delivery device of claim 1 , wherein the one or more outlets are oriented (a) along a longitudinal axis of the body to provide a luminal delivery of the fluid, and/or (b) transverse to a longitudinal axis of the body to provide a radial delivery of the fluid. 7. The ingestible fluid delivery device of claim 1 , wherein the treated substrate of the ultrasonic resonance member comprises a treated glass substrate. 8. A drug delivery device comprising: a container defining an interior with an outlet, the interior defined by at least one wall; an ultrasonic resonance member comprising at least a portion of the at least one wall of the container, the ultrasonic resonance member comprising a treated substrate and having a fluid interface surface in contact with a fluid therapeutic disposed within the interior, the fluid interface surface aligned with the outlet of the container; and a laser light source oriented and configured to direct a pulsed light beam at the ultrasonic resonance member to urge a fluid therapeutic disposed within the container into a jet stream, wherein the laser light source comprises an array of laser light sources, the array including a plurality of laser light sources disposed about a circumference of the container and configured to be sequentially activated around the circumference to create a vortex in a therapeutic fluid in the container and a central laser light source configured to direct the vortex toward the outlet. 9. The drug delivery device of claim 8 , wherein the treated substrate of the ultrasonic resonance member comprises a treated glass substrate. 10. A drug delivery device comprising: a first container defining an interior with an outlet; a first ultrasonic resonance member, the first ultrasonic resonance member comprising a treated substrate and having a fluid interface surface in contact with a fluid therapeutic disposed within the interior, the fluid interface surface aligned with the outlet of the first container; a laser light source oriented and configured to direct a pulsed light beam at the ultrasonic resonance member to urge a fluid therapeutic disposed within the container into a jet stream; a second container defining an interior with an outlet; and a second ultrasonic resonance member comprising a treated substrate having a fluid interface surface in contact with a fluid therapeutic disposed within the interior of the second container, the fluid interface surface of the second ultrasonic resonance member aligned with the outlet of the second container, wherein the outlets of the first and second containers are fluidly connected by a combined conduit. 11. The drug delivery device of claim 10 , wherein the laser light source comprises a first laser light source; and further comprising a second laser light source, the second laser light source oriented and configured to direct a pulsed light beam into the second ultrasonic resonance member to urge a fluid therapeutic disposed within the second container into a jet stream. 12. The drug delivery device of claim 11 , wherein the fluid therapeutics disposed within the interiors of the first and second containers comprise a first fluid therapeutic and a second fluid therapeutic; and vortices generated by the jet streams within the first and second containers mix the first and second fluid therapeutics together to deliver a mixture. 13. The drug delivery device of claim 11 , wherein vortices generated by the jet streams within the first and second containers reconstitute a lyophilized drug compound using a diluent solution. 14. The drug delivery device of claim 10 , wherein the first and second ultrasonic resonance members comprise a single-piece plate member; and the laser light source is oriented to direct a pulsed light beam along a longitudinal axis of the single-piece plate member to urge fluid therapeutics disposed within the first and second containers into jet streams to drive the fluid therapeutics through the outlets of the first and second containers, respectively, mixing the fluid therapeutics together. 15. The drug delivery device of claim 14 , wherein the fluid therapeutics disposed within the interiors of the first and second containers comprise a first fluid therapeutic and a second fluid therapeutic, the second fluid therapeutic being different than the first fluid therapeutic. 16. The drug delivery device of claim 10 , wherein the treated substrate of the second ultrasonic resonance member comprises a treated glass substrate.
Media being expelled from injector by pressurised fluid or vacuum (for infusion A61M5/145, A61M5/155) · CPC title
Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 {, A61M5/46} take precedence; {hypodermic projectiles F42B12/54}) · CPC title
Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title
with specially designed jet passages at the injector's distal end · CPC title
comprising means for injection of two or more media, e.g. by mixing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.